Clinical and economical impact of multiplex respiratory virus assays
- PMID: 23601453
- PMCID: PMC7132665
- DOI: 10.1016/j.diagmicrobio.2013.03.008
Clinical and economical impact of multiplex respiratory virus assays
Abstract
During the last decade, a variety of molecular assays targeting respiratory viruses have been developed and commercialized. Therefore, multiplex PCR are increasingly used in everyday clinical practice. This improves our understanding of respiratory virus epidemiology and enhances our concerns about their clinical impact in specific patient populations. However, questions remain regarding cost-effectiveness of performing these diagnostic tests in routine and their real impact on patient care. This article will review available data and highlight unresolved questions about cost-effectiveness, infection control, clinical utility and public health impact of multiplex respiratory virus assays.
Copyright © 2013 Elsevier Inc. All rights reserved.
References
-
- Abanses J.C., Dowd M.D., Simon S.D., Sharma V. Impact of rapid influenza testing at triage on management of febrile infants and young children. Pediatr Emerg Care. 2006;22(3):145–149. - PubMed
-
- Aberle J.H., Aberle S.W., Pracher E., Hutter H.P., Kundi M., Popow-Kraupp T. Single versus dual respiratory virus infections in hospitalized infants: impact on clinical course of disease and interferon-gamma response. Pediatr Infect Dis J. 2005;24(7):605–610. - PubMed
-
- Armstrong D., Grimwood K., Carlin J.B., Carzino R., Hull J., Olinsky A. Severe viral respiratory infections in infants with cystic fibrosis. Pediatr Pulmonol. 1998;26(6):371–379. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
